Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-09-11

AUTHORS

Natsu Otowa-Suematsu, Kazuhiko Sakaguchi, Tomoaki Nakamura, Kenta Hara, Minoru Kishi, Naoko Hashimoto, Kazuki Yokota, Hiroshi Yoshino, Yasuo Kuroki, Tomoko Nishiumi, Anna Sou, Hisako Komada, Yuko Okada, Yushi Hirota, Yoshikazu Tamori, Wataru Ogawa

ABSTRACT

INTRODUCTION: We comprehensively evaluated the effects of combination therapy with insulin glargine and the incretin-based drugs lixisenatide or vildagliptin in Japanese patients with type 2 diabetes. METHODS: In this 12-week, randomized, open-label, parallel-group, multicenter study (GLP-ONE Kobe), the incretin-based drug sitagliptin was randomly switched to lixisenatide (20 μg/day, n = 18) or vildagliptin (100 mg/day, n = 20) in patients with inadequate glycemic control despite combination therapy with insulin glargine and sitagliptin. The dose of insulin glargine was titrated after the switch to maintain fasting blood glucose at approximately 110 mg/dL. The primary end points of the study were the change in glycosylated hemoglobin (HbA1c) level between before and 12 weeks after the treatment switch, the proportion of patients achieving an HbA1c level below 7.0%, and the postprandial increase in glucose concentration as assessed by self-monitoring of blood glucose. RESULTS: The change in HbA1c level from baseline to 12 weeks did not differ significantly between the lixisenatide and vildagliptin groups (- 0.6 ± 0.7% and - 0.6 ± 1.2%, respectively, P = 0.920). Neither the proportion of patients achieving an HbA1c level below 7.0% nor the postprandial increase in glucose concentration was different between two groups. Body weight and serum low density lipoprotein (LDL) cholesterol level decreased significantly in the lixisenatide and vildagliptin groups, respectively. Both drugs were associated with mild gastrointestinal symptoms but not with severe hypoglycemia. Vildagliptin was associated with elevation of serum aspartate transaminase. Treatment satisfaction as assessed with the Diabetes Treatment Satisfaction Questionnaire did not differ significantly between the two groups. CONCLUSION: The combinations of basal insulin and either lixisenatide or vildagliptin have similar efficacies with regard to improvement of glycemic control. TRIAL REGISTRATION: This trial has been registered with UMIN (No. 000010769). More... »

PAGES

2067-2079

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-018-0505-2

DOI

http://dx.doi.org/10.1007/s13300-018-0505-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106915635

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30206903


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Otowa-Suematsu", 
        "givenName": "Natsu", 
        "id": "sg:person.010747363363.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010747363363.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
            "Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakaguchi", 
        "givenName": "Kazuhiko", 
        "id": "sg:person.01235252323.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235252323.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakamura", 
        "givenName": "Tomoaki", 
        "id": "sg:person.0716204014.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716204014.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diabetes and Endocrine disease, Kita-harima Medical Center, Ono, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Diabetes and Endocrine disease, Kita-harima Medical Center, Ono, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hara", 
        "givenName": "Kenta", 
        "id": "sg:person.01076473106.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076473106.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Nishiwaki Municipal Hospital, Nishiwaki, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Nishiwaki Municipal Hospital, Nishiwaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kishi", 
        "givenName": "Minoru", 
        "id": "sg:person.01104132611.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104132611.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diabetes and Endocrinology, Hyogo Brain and Heart Center, Himeji, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417753.3", 
          "name": [
            "Department of Diabetes and Endocrinology, Hyogo Brain and Heart Center, Himeji, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hashimoto", 
        "givenName": "Naoko", 
        "id": "sg:person.0707464726.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707464726.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Jinkeikai Ishii Hospital, Akashi, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Jinkeikai Ishii Hospital, Akashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokota", 
        "givenName": "Kazuki", 
        "id": "sg:person.0714374654.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714374654.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Shinsuma General Hospital, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Shinsuma General Hospital, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshino", 
        "givenName": "Hiroshi", 
        "id": "sg:person.0754311054.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754311054.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Kobe Century Memorial Hospital, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Kobe Century Memorial Hospital, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuroki", 
        "givenName": "Yasuo", 
        "id": "sg:person.0613041544.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613041544.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diabetes and Endocrinology, Kobe Rosai Hospital, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415418.d", 
          "name": [
            "Department of Diabetes and Endocrinology, Kobe Rosai Hospital, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nishiumi", 
        "givenName": "Tomoko", 
        "id": "sg:person.01265503507.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265503507.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sou", 
        "givenName": "Anna", 
        "id": "sg:person.012451556107.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012451556107.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komada", 
        "givenName": "Hisako", 
        "id": "sg:person.0743761741.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743761741.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okada", 
        "givenName": "Yuko", 
        "id": "sg:person.014646032412.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014646032412.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hirota", 
        "givenName": "Yushi", 
        "id": "sg:person.0626074623.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626074623.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Creative Health Promotion, Department of Social/Community Medicine and Health Science, Kobe University Graduate School of Medicine, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
            "Division of Creative Health Promotion, Department of Social/Community Medicine and Health Science, Kobe University Graduate School of Medicine, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tamori", 
        "givenName": "Yoshikazu", 
        "id": "sg:person.01271650614.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271650614.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ogawa", 
        "givenName": "Wataru", 
        "id": "sg:person.01327530536.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327530536.48"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12020-015-0841-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003694038", 
          "https://doi.org/10.1007/s12020-015-0841-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/j.pharep.2014.07.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047987511", 
          "https://doi.org/10.1016/j.pharep.2014.07.016"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1475-2840-11-92", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003940754", 
          "https://doi.org/10.1186/1475-2840-11-92"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/srep35633", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041142407", 
          "https://doi.org/10.1038/srep35633"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrendo.2012.140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011731640", 
          "https://doi.org/10.1038/nrendo.2012.140"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-09-11", 
    "datePublishedReg": "2018-09-11", 
    "description": "INTRODUCTION: We comprehensively evaluated the effects of combination therapy with insulin glargine and the incretin-based drugs lixisenatide or vildagliptin in Japanese patients with type 2 diabetes.\nMETHODS: In this 12-week, randomized, open-label, parallel-group, multicenter study (GLP-ONE Kobe), the incretin-based drug sitagliptin was randomly switched to lixisenatide (20\u00a0\u03bcg/day, n\u2009=\u200918) or vildagliptin (100\u00a0mg/day, n\u2009=\u200920) in patients with inadequate glycemic control despite combination therapy with insulin glargine and sitagliptin. The dose of insulin glargine was titrated after the switch to maintain fasting blood glucose at approximately 110\u00a0mg/dL. The primary end points of the study were the change in glycosylated hemoglobin (HbA1c) level between before and 12\u00a0weeks after the treatment switch, the proportion of patients achieving an HbA1c level below 7.0%, and the postprandial increase in glucose concentration as assessed by self-monitoring of blood glucose.\nRESULTS: The change in HbA1c level from baseline to 12\u00a0weeks did not differ significantly between the lixisenatide and vildagliptin groups (-\u20090.6\u2009\u00b1\u20090.7% and -\u20090.6\u2009\u00b1\u20091.2%, respectively, P\u2009=\u20090.920). Neither the proportion of patients achieving an HbA1c level below 7.0% nor the postprandial increase in glucose concentration was different between two groups. Body weight and serum low density lipoprotein (LDL) cholesterol level decreased significantly in the lixisenatide and vildagliptin groups, respectively. Both drugs were associated with mild gastrointestinal symptoms but not with severe hypoglycemia. Vildagliptin was associated with elevation of serum aspartate transaminase. Treatment satisfaction as assessed with the Diabetes Treatment Satisfaction Questionnaire did not differ significantly between the two groups.\nCONCLUSION: The combinations of basal insulin and either lixisenatide or vildagliptin have similar efficacies with regard to improvement of glycemic control.\nTRIAL REGISTRATION: This trial has been registered with UMIN (No. 000010769).", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13300-018-0505-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "proportion of patients", 
      "insulin glargine", 
      "combination therapy", 
      "vildagliptin group", 
      "glycemic control", 
      "basal insulin", 
      "multicenter study", 
      "blood glucose", 
      "postprandial increase", 
      "Japanese patients", 
      "serum low-density lipoprotein cholesterol levels", 
      "low-density lipoprotein cholesterol levels", 
      "density lipoprotein cholesterol levels", 
      "Diabetes Treatment Satisfaction Questionnaire", 
      "inadequate glycemic control", 
      "primary end point", 
      "mild gastrointestinal symptoms", 
      "Treatment Satisfaction Questionnaire", 
      "lipoprotein cholesterol levels", 
      "serum aspartate transaminase", 
      "type 2 diabetes", 
      "glucose concentration", 
      "open label", 
      "gastrointestinal symptoms", 
      "severe hypoglycemia", 
      "treatment satisfaction", 
      "hemoglobin levels", 
      "treatment switch", 
      "cholesterol levels", 
      "parallel group", 
      "similar efficacy", 
      "lixisenatide", 
      "aspartate transaminase", 
      "body weight", 
      "patients", 
      "type 2", 
      "vildagliptin", 
      "glargine", 
      "end point", 
      "satisfaction questionnaire", 
      "therapy", 
      "sitagliptin", 
      "insulin", 
      "weeks", 
      "group", 
      "glucose", 
      "HbA", 
      "levels", 
      "hypoglycemia", 
      "diabetes", 
      "symptoms", 
      "proportion", 
      "transaminase", 
      "dose", 
      "baseline", 
      "trials", 
      "study", 
      "drugs", 
      "efficacy", 
      "control", 
      "questionnaire", 
      "comprehensive evaluation", 
      "elevation", 
      "increase", 
      "UMIN", 
      "changes", 
      "concentration", 
      "weight", 
      "satisfaction", 
      "evaluation", 
      "effect", 
      "improvement", 
      "regard", 
      "combination", 
      "point", 
      "switch", 
      "incretin-based drugs lixisenatide", 
      "drugs lixisenatide", 
      "incretin-based drug sitagliptin", 
      "drug sitagliptin"
    ], 
    "name": "Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study", 
    "pagination": "2067-2079", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106915635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-018-0505-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30206903"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-018-0505-2", 
      "https://app.dimensions.ai/details/publication/pub.1106915635"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_777.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13300-018-0505-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0505-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0505-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0505-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0505-2'


 

This table displays all metadata directly associated to this object as RDF triples.

288 TRIPLES      22 PREDICATES      111 URIs      98 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-018-0505-2 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nb226898a6d794b67b9abf573e91d08ef
4 schema:citation sg:pub.10.1007/s12020-015-0841-1
5 sg:pub.10.1016/j.pharep.2014.07.016
6 sg:pub.10.1038/nrendo.2012.140
7 sg:pub.10.1038/srep35633
8 sg:pub.10.1186/1475-2840-11-92
9 schema:datePublished 2018-09-11
10 schema:datePublishedReg 2018-09-11
11 schema:description INTRODUCTION: We comprehensively evaluated the effects of combination therapy with insulin glargine and the incretin-based drugs lixisenatide or vildagliptin in Japanese patients with type 2 diabetes. METHODS: In this 12-week, randomized, open-label, parallel-group, multicenter study (GLP-ONE Kobe), the incretin-based drug sitagliptin was randomly switched to lixisenatide (20 μg/day, n = 18) or vildagliptin (100 mg/day, n = 20) in patients with inadequate glycemic control despite combination therapy with insulin glargine and sitagliptin. The dose of insulin glargine was titrated after the switch to maintain fasting blood glucose at approximately 110 mg/dL. The primary end points of the study were the change in glycosylated hemoglobin (HbA<sub>1c</sub>) level between before and 12 weeks after the treatment switch, the proportion of patients achieving an HbA<sub>1c</sub> level below 7.0%, and the postprandial increase in glucose concentration as assessed by self-monitoring of blood glucose. RESULTS: The change in HbA<sub>1c</sub> level from baseline to 12 weeks did not differ significantly between the lixisenatide and vildagliptin groups (- 0.6 ± 0.7% and - 0.6 ± 1.2%, respectively, P = 0.920). Neither the proportion of patients achieving an HbA<sub>1c</sub> level below 7.0% nor the postprandial increase in glucose concentration was different between two groups. Body weight and serum low density lipoprotein (LDL) cholesterol level decreased significantly in the lixisenatide and vildagliptin groups, respectively. Both drugs were associated with mild gastrointestinal symptoms but not with severe hypoglycemia. Vildagliptin was associated with elevation of serum aspartate transaminase. Treatment satisfaction as assessed with the Diabetes Treatment Satisfaction Questionnaire did not differ significantly between the two groups. CONCLUSION: The combinations of basal insulin and either lixisenatide or vildagliptin have similar efficacies with regard to improvement of glycemic control. TRIAL REGISTRATION: This trial has been registered with UMIN (No. 000010769).
12 schema:genre article
13 schema:inLanguage en
14 schema:isAccessibleForFree true
15 schema:isPartOf N7a0c81c440e1407c9c5d2bfc8c1e9495
16 Nafc62e98903b4a6db400addde1459892
17 sg:journal.1044057
18 schema:keywords Diabetes Treatment Satisfaction Questionnaire
19 HbA
20 Japanese patients
21 Treatment Satisfaction Questionnaire
22 UMIN
23 aspartate transaminase
24 basal insulin
25 baseline
26 blood glucose
27 body weight
28 changes
29 cholesterol levels
30 combination
31 combination therapy
32 comprehensive evaluation
33 concentration
34 control
35 density lipoprotein cholesterol levels
36 diabetes
37 dose
38 drug sitagliptin
39 drugs
40 drugs lixisenatide
41 effect
42 efficacy
43 elevation
44 end point
45 evaluation
46 gastrointestinal symptoms
47 glargine
48 glucose
49 glucose concentration
50 glycemic control
51 group
52 hemoglobin levels
53 hypoglycemia
54 improvement
55 inadequate glycemic control
56 increase
57 incretin-based drug sitagliptin
58 incretin-based drugs lixisenatide
59 insulin
60 insulin glargine
61 levels
62 lipoprotein cholesterol levels
63 lixisenatide
64 low-density lipoprotein cholesterol levels
65 mild gastrointestinal symptoms
66 multicenter study
67 open label
68 parallel group
69 patients
70 point
71 postprandial increase
72 primary end point
73 proportion
74 proportion of patients
75 questionnaire
76 regard
77 satisfaction
78 satisfaction questionnaire
79 serum aspartate transaminase
80 serum low-density lipoprotein cholesterol levels
81 severe hypoglycemia
82 similar efficacy
83 sitagliptin
84 study
85 switch
86 symptoms
87 therapy
88 transaminase
89 treatment satisfaction
90 treatment switch
91 trials
92 type 2
93 type 2 diabetes
94 vildagliptin
95 vildagliptin group
96 weeks
97 weight
98 schema:name Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study
99 schema:pagination 2067-2079
100 schema:productId N3cca151357f341a8a6e2a02290249cf9
101 Nb3ced7a99aab42fd8837c8decd2a7ae5
102 Nf1fb851acb504b6b91f0d6460fa43359
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106915635
104 https://doi.org/10.1007/s13300-018-0505-2
105 schema:sdDatePublished 2022-01-01T18:50
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher Nfcc56df604a04432b9ae17baaee9425e
108 schema:url https://doi.org/10.1007/s13300-018-0505-2
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N1698a4dfda6841f7ba89ccc70a59f910 rdf:first sg:person.0716204014.29
113 rdf:rest N45e298699ef146aa99c7548fd1f9067a
114 N2e8df26f45c2427390db16e50d15d712 rdf:first sg:person.01235252323.09
115 rdf:rest N1698a4dfda6841f7ba89ccc70a59f910
116 N3195a22fdb7748069bda6166c9ce758d rdf:first sg:person.014646032412.39
117 rdf:rest Nb43cc8d7085b49b09d204613677b27cb
118 N3cca151357f341a8a6e2a02290249cf9 schema:name dimensions_id
119 schema:value pub.1106915635
120 rdf:type schema:PropertyValue
121 N3d14765df425413b8833a6c566bebf9a rdf:first sg:person.01327530536.48
122 rdf:rest rdf:nil
123 N45e298699ef146aa99c7548fd1f9067a rdf:first sg:person.01076473106.08
124 rdf:rest Naf04ae6f4c4c46418940a86b2cba3070
125 N57fb5ea80c2f4cbb81a051fd97f403ff rdf:first sg:person.0707464726.52
126 rdf:rest Nbc71d661e55d49509ed71c9a69b94591
127 N5881931538b34ab798968ac03b623cbe rdf:first sg:person.0754311054.13
128 rdf:rest N985c805a1b124821a18630509146dd6e
129 N5bf4cb49f39b4d39a8a0d8ae2f0f7b49 rdf:first sg:person.01271650614.49
130 rdf:rest N3d14765df425413b8833a6c566bebf9a
131 N703f92154af0431795277a8576ba52ff rdf:first sg:person.0743761741.13
132 rdf:rest N3195a22fdb7748069bda6166c9ce758d
133 N7a0c81c440e1407c9c5d2bfc8c1e9495 schema:volumeNumber 9
134 rdf:type schema:PublicationVolume
135 N985c805a1b124821a18630509146dd6e rdf:first sg:person.0613041544.37
136 rdf:rest Nc01325b220b949718498d29d3b97910d
137 Na015d269ddaf4f43a7c3e5f25ceb1445 rdf:first sg:person.012451556107.99
138 rdf:rest N703f92154af0431795277a8576ba52ff
139 Naf04ae6f4c4c46418940a86b2cba3070 rdf:first sg:person.01104132611.36
140 rdf:rest N57fb5ea80c2f4cbb81a051fd97f403ff
141 Nafc62e98903b4a6db400addde1459892 schema:issueNumber 5
142 rdf:type schema:PublicationIssue
143 Nb226898a6d794b67b9abf573e91d08ef rdf:first sg:person.010747363363.02
144 rdf:rest N2e8df26f45c2427390db16e50d15d712
145 Nb3ced7a99aab42fd8837c8decd2a7ae5 schema:name doi
146 schema:value 10.1007/s13300-018-0505-2
147 rdf:type schema:PropertyValue
148 Nb43cc8d7085b49b09d204613677b27cb rdf:first sg:person.0626074623.99
149 rdf:rest N5bf4cb49f39b4d39a8a0d8ae2f0f7b49
150 Nbc71d661e55d49509ed71c9a69b94591 rdf:first sg:person.0714374654.31
151 rdf:rest N5881931538b34ab798968ac03b623cbe
152 Nc01325b220b949718498d29d3b97910d rdf:first sg:person.01265503507.91
153 rdf:rest Na015d269ddaf4f43a7c3e5f25ceb1445
154 Nf1fb851acb504b6b91f0d6460fa43359 schema:name pubmed_id
155 schema:value 30206903
156 rdf:type schema:PropertyValue
157 Nfcc56df604a04432b9ae17baaee9425e schema:name Springer Nature - SN SciGraph project
158 rdf:type schema:Organization
159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
160 schema:name Medical and Health Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
163 schema:name Clinical Sciences
164 rdf:type schema:DefinedTerm
165 sg:journal.1044057 schema:issn 1869-6953
166 1869-6961
167 schema:name Diabetes Therapy
168 schema:publisher Springer Nature
169 rdf:type schema:Periodical
170 sg:person.010747363363.02 schema:affiliation grid-institutes:grid.31432.37
171 schema:familyName Otowa-Suematsu
172 schema:givenName Natsu
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010747363363.02
174 rdf:type schema:Person
175 sg:person.01076473106.08 schema:affiliation grid-institutes:None
176 schema:familyName Hara
177 schema:givenName Kenta
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076473106.08
179 rdf:type schema:Person
180 sg:person.01104132611.36 schema:affiliation grid-institutes:None
181 schema:familyName Kishi
182 schema:givenName Minoru
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104132611.36
184 rdf:type schema:Person
185 sg:person.01235252323.09 schema:affiliation grid-institutes:grid.31432.37
186 schema:familyName Sakaguchi
187 schema:givenName Kazuhiko
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235252323.09
189 rdf:type schema:Person
190 sg:person.012451556107.99 schema:affiliation grid-institutes:grid.31432.37
191 schema:familyName Sou
192 schema:givenName Anna
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012451556107.99
194 rdf:type schema:Person
195 sg:person.01265503507.91 schema:affiliation grid-institutes:grid.415418.d
196 schema:familyName Nishiumi
197 schema:givenName Tomoko
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265503507.91
199 rdf:type schema:Person
200 sg:person.01271650614.49 schema:affiliation grid-institutes:grid.31432.37
201 schema:familyName Tamori
202 schema:givenName Yoshikazu
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271650614.49
204 rdf:type schema:Person
205 sg:person.01327530536.48 schema:affiliation grid-institutes:grid.31432.37
206 schema:familyName Ogawa
207 schema:givenName Wataru
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327530536.48
209 rdf:type schema:Person
210 sg:person.014646032412.39 schema:affiliation grid-institutes:grid.31432.37
211 schema:familyName Okada
212 schema:givenName Yuko
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014646032412.39
214 rdf:type schema:Person
215 sg:person.0613041544.37 schema:affiliation grid-institutes:None
216 schema:familyName Kuroki
217 schema:givenName Yasuo
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613041544.37
219 rdf:type schema:Person
220 sg:person.0626074623.99 schema:affiliation grid-institutes:grid.31432.37
221 schema:familyName Hirota
222 schema:givenName Yushi
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626074623.99
224 rdf:type schema:Person
225 sg:person.0707464726.52 schema:affiliation grid-institutes:grid.417753.3
226 schema:familyName Hashimoto
227 schema:givenName Naoko
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707464726.52
229 rdf:type schema:Person
230 sg:person.0714374654.31 schema:affiliation grid-institutes:None
231 schema:familyName Yokota
232 schema:givenName Kazuki
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714374654.31
234 rdf:type schema:Person
235 sg:person.0716204014.29 schema:affiliation grid-institutes:grid.31432.37
236 schema:familyName Nakamura
237 schema:givenName Tomoaki
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716204014.29
239 rdf:type schema:Person
240 sg:person.0743761741.13 schema:affiliation grid-institutes:grid.31432.37
241 schema:familyName Komada
242 schema:givenName Hisako
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743761741.13
244 rdf:type schema:Person
245 sg:person.0754311054.13 schema:affiliation grid-institutes:None
246 schema:familyName Yoshino
247 schema:givenName Hiroshi
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754311054.13
249 rdf:type schema:Person
250 sg:pub.10.1007/s12020-015-0841-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003694038
251 https://doi.org/10.1007/s12020-015-0841-1
252 rdf:type schema:CreativeWork
253 sg:pub.10.1016/j.pharep.2014.07.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047987511
254 https://doi.org/10.1016/j.pharep.2014.07.016
255 rdf:type schema:CreativeWork
256 sg:pub.10.1038/nrendo.2012.140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011731640
257 https://doi.org/10.1038/nrendo.2012.140
258 rdf:type schema:CreativeWork
259 sg:pub.10.1038/srep35633 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041142407
260 https://doi.org/10.1038/srep35633
261 rdf:type schema:CreativeWork
262 sg:pub.10.1186/1475-2840-11-92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003940754
263 https://doi.org/10.1186/1475-2840-11-92
264 rdf:type schema:CreativeWork
265 grid-institutes:None schema:alternateName Department of Diabetes and Endocrine disease, Kita-harima Medical Center, Ono, Japan
266 Department of Internal Medicine, Jinkeikai Ishii Hospital, Akashi, Japan
267 Department of Internal Medicine, Kobe Century Memorial Hospital, Kobe, Japan
268 Department of Internal Medicine, Nishiwaki Municipal Hospital, Nishiwaki, Japan
269 Department of Internal Medicine, Shinsuma General Hospital, Kobe, Japan
270 schema:name Department of Diabetes and Endocrine disease, Kita-harima Medical Center, Ono, Japan
271 Department of Internal Medicine, Jinkeikai Ishii Hospital, Akashi, Japan
272 Department of Internal Medicine, Kobe Century Memorial Hospital, Kobe, Japan
273 Department of Internal Medicine, Nishiwaki Municipal Hospital, Nishiwaki, Japan
274 Department of Internal Medicine, Shinsuma General Hospital, Kobe, Japan
275 rdf:type schema:Organization
276 grid-institutes:grid.31432.37 schema:alternateName Division of Creative Health Promotion, Department of Social/Community Medicine and Health Science, Kobe University Graduate School of Medicine, Kobe, Japan
277 Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
278 Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
279 schema:name Division of Creative Health Promotion, Department of Social/Community Medicine and Health Science, Kobe University Graduate School of Medicine, Kobe, Japan
280 Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
281 Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
282 rdf:type schema:Organization
283 grid-institutes:grid.415418.d schema:alternateName Department of Diabetes and Endocrinology, Kobe Rosai Hospital, Kobe, Japan
284 schema:name Department of Diabetes and Endocrinology, Kobe Rosai Hospital, Kobe, Japan
285 rdf:type schema:Organization
286 grid-institutes:grid.417753.3 schema:alternateName Department of Diabetes and Endocrinology, Hyogo Brain and Heart Center, Himeji, Japan
287 schema:name Department of Diabetes and Endocrinology, Hyogo Brain and Heart Center, Himeji, Japan
288 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...